Wharton’s Jelly-Derived Mesenchymal Stromal Cells as a Promising Cellular Therapeutic Strategy for the Management of Graft-versus-Host Disease
2015 ◽
Vol 26
(1)
◽
pp. 50-57
◽
2014 ◽
pp. 45
◽
2013 ◽
Vol 55
(5)
◽
pp. 1203-1205
◽
Keyword(s):